Best pharmaceutical ETFs to buy in 2024

Pharmaceutical ETFs offer investors exposure to some of the best and most profitable pharma companies in the world. The guide picks five of the top ETFs you can invest in right now.
By:
Updated: Oct 11, 2022
Listen

Trade your favourite markets with our top-rated broker, Plus500.

4.5/5

CFD service. 82% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you can afford to take the high risk of losing your money.

Visit site

Pharmaceutical ETFs are funds that invest in companies that form part of the $1 trillion pharma industry. They often contain businesses that manufacture some of the world’s most used drugs. This guide picks five of the top pharma ETFs for the year ahead. 

What are the top pharmaceutical ETFs to buy?

Copy link to section

Our experts have selected five of the most promising ETFs for this year listed in the table below. To find more information on each one, scroll down to keep reading. 

#ETF symbolETF nameWhere to Trade
1IHEiShares US Pharmaceuticals
Buy IHE

Buy or sell stock CFDs with Plus500. 82% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you can afford to take the high risk of losing your money.

2CHNALoncar China BioPharma
Buy CHNA

Buy or sell stock CFDs with Plus500. 82% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you can afford to take the high risk of losing your money.

3PPHVanEck Pharmaceutical
Buy PPH

Buy or sell stock CFDs with Plus500. 82% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you can afford to take the high risk of losing your money.

4PJPInvesco Dynamic Pharmaceuticals
Buy PJP

Buy or sell stock CFDs with Plus500. 82% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you can afford to take the high risk of losing your money.

5PILLDirexion Daily Pharmaceuticals & Medical Bull
Buy PILL

Buy or sell stock CFDs with Plus500. 82% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you can afford to take the high risk of losing your money.

List selected by our team of analysts, updated 21 July 2022

1. iShare US Pharmaceuticals  (NYSEARCA: IHE)

Copy link to section

The IHE ETF gives exposure to US companies that manufacture prescription or over-the-counter drugs and vaccines. Created in 2006, the ETF seeks to track the performance of the Dow Jones US Select Pharmaceuticals index. 

IHE is composed of just under fifty companies and is heavily weighted towards large-cap stocks. Its top two holdings, Johnson & Johnson, and Pfizer account for over 40% of its invested capital. Both are large well-known companies, with Pfizer bolstering the ETFs performance in 2020 after its covid vaccine rollout. 

The reason the iShare UK Pharmaceuticals takes the top spot on our list is due to its solid prior growth of nearly 300% since inception. It also holds some of the largest pharma companies in the world and its strong performance during the pandemic confirms its ability to hold up in all economic conditions. 

Sign-up & trade IHE ETF

CFD service. 82% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you can afford to take the high risk of losing your money.

2. Loncar China BioPharma (NASDAQ: CHNA)

Copy link to section

The second spot on our list goes to the Loncar China BioPharma ETF, which contains both Chinese and US pharmaceutical companies. It seeks to track the performance of the Loncar China BioPharma Index. While it holds companies on both the NASDAQ and Hong Kong Stock Exchanges, it has a larger weighting towards Chinese companies. 

Around 80% of the ETF comprises pharma companies located in China and it has an equal weighting across all of its holdings, amounting to an average of about 2%. Its largest two holdings are BeiGene ADR and CARsgen Therapeutics Holdings. BeiGene engages in the development of cancer drugs while CARsgen develops antigen receptor cell therapies. 

It’s one of the youngest ETFs on our list and was created in 2018. Since its inception, it has performed well, especially during the covid pandemic which saw its price increase in excess of 100%. It has since slowed down but takes the second place due to its heavy exposure to the growing Chinese pharmaceutical market. 

Sign-up & trade CHNA ETF

CFD service. 82% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you can afford to take the high risk of losing your money.

3. VanEck Pharmaceutical (NASDAQ: PPH)

Copy link to section

The VanEck ETF aims to track the performance of an index called the MVIS US Listed Pharmaceutical. It is the joint smallest ETF on our list in terms of holdings, with just 25, however many of its companies are large-cap stocks. 

Unlike the previous two ETFs on our list, PPH includes companies from around the world, with the majority located in the US or Europe. The ETFs top ten holdings account for 50% of its total weighting and included companies like Glaxosmithkline, Johnson & Johnson, and Merck and Co. 

Although PPH holds a small number of companies, it favours the largest businesses in the pharmaceutical industry based on market capitalisation. Due to its stable and consistent growth since its inception in 2000, our analysts believe it is one of the top pharma ETFs to invest in in the coming year. 

Sign-up & trade PPH ETF

CFD service. 82% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you can afford to take the high risk of losing your money.

4. Invesco Dynamic Pharmaceuticals  (NYSEARCA: PJP)

Copy link to section

The Invesco Dynamic Pharmaceuticals ETF is the best performing on our list. Since its inception in 2005, it has seen an increase of over 400%. Like PPH above, it’s the joint smallest on our list with just 25 holdings. 

It tracks the performance of an index called Dynamic Pharmaceutical Intellidex and is focused on giving investors exposure to US-based pharma companies. Its top three holdings account for nearly 20% of its total size. They include Merck & co, Pfizer, and Abbott Laboratories. 

Similarly to most ETFs on our list, it took a hit during the coronavirus pandemic but has quickly recovered in the time since. It takes fourth place due to its concentration of large industry-leading companies and previous growth. 

Sign-up & trade PJP ETF

CFD service. 82% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you can afford to take the high risk of losing your money.

5. Direxion Daily Pharmaceuticals & Medical Bull  (NYSEARCA: PILL)

Copy link to section

The final ETF on our list is the Direxion Daily Pharmaceuticals & Medical Bull. Its aim is to track an index called the S&P Pharmaceuticals Select Industry Index. However, unlike the others on our list, PILL is a leveraged ETF. 

While unlevered ETFs track an index’s performance long term, PILL has an investment objective that is 300% the return of the index it tracks per day. Investing in this ETF is a riskier choice compared to the four we have listed prior. Its top ten holdings amount to 50% of its total and are all US-based companies. 

Its largest holding is Cassava Sciences, which is a clinical-stage biopharm company that focuses on neuroscience. Although risky, PILL takes the last spot on our list because of the potential short term gains on offer. Out of the five ETFs, PILL was the strongest performer during the pandemic, returning over 300% to investors. 

Sign-up & trade PILL ETF

CFD service. 82% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you can afford to take the high risk of losing your money.

Where to buy the best pharmaceutical  ETFs

Copy link to section

If you are ready to invest in pharmaceutical ETFs, finding a reliable platform key. Below we’ve listed three of our expertly selected brokers. You can click on any and be taken directly to their website and start investing and you can read more about them in this article: best ETF platforms

Sort by:

1
Min. Deposit
$ 100
Best offer
User Score
10
Trade +2000 CFDs on Shares, Options, Commodities & more
Unlimited risk-free Demo Account
0 commissions & attractive spreads with up to 1:5 leverage
Start Trading
Payment Methods:
American Express, Apple Pay, Bank Transfer, Credit Card, Debit Card, Discover, Google Pay, Mastercard, PayPal, SEPA, Trustly, Visa, , skrill
Full Regulations:
ASIC, FCA, FSA, MAS, cysec-250-14-regulator, isa-regulator

CFD service. 82% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you can afford to take the high risk of losing your money.

2
Min. Deposit
$ 10
Best offer
User Score
9.9
Up to $240 bonus!
Deposit with ACA, Wire, Pay with my bank
Invest for dividends and get payout on stocks on Ex-Dividend day
Start Trading
Payment Methods:
Bank Transfer, Credit Card, Debit Card, PayPal, Wire Transfer
Full Regulations:
CySEC, FCA

Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. Invezz.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB.

3
Min. Deposit
$ 0
Best offer
User Score
9.6
Get insights from millions of investors, creators, and analysts
Build your portfolio of stocks, ETFs, and crypto–all in one place
No minimum deposit
Start Trading
Payment Methods:
Bank Wire, Check, Debit Card, Wire Transfer
Full Regulations:
Cryptocurrency execution and custody services are provided by Apex Crypto LLC (NMLS ID 1828849) through a software licensing agreement between Apex Crypto LLC and Public Crypto LLC. Crypto trading on Public platforms is served by Public Crypto LLC and offered through APEX Crypto. Please ensure that you fully understand the risks involved before trading.

What is a pharmaceutical  ETF?

Copy link to section

Pharmaceutical exchange-traded funds offer investors exposure to some of the largest pharma companies in the world. These include businesses that research, discover, develop, and manufacture drugs used to cure diseases and vaccines among others. 

ETFs are an easy way for investors to generate returns from a specific sector without having to buy individual stocks. The pharmaceutical industry is one of the most popular amongst investors with large returns on offer. It’s currently a $1 trillion market and benefited in recent times from heavyweights competing to deliver a covid vaccine. 

Are pharmaceutical  ETFs a good investment?

Copy link to section

Yes they can be, especially if you’re looking for slow and steady growth rather than explosive gains. The pharmaceutical industry includes some of the largest companies in the world, many of which have led the race in producing a covid vaccine. 

Pharmaceutical ETFs have an advantage over other industries, in that they offer stability and often perform better during times of economic downturn. This was highlighted during the pandemic which saw the pharma sector outperform other industries. Investing in pharma ETFs is a great way to balance a portfolio while reducing risk. 

Much of the industry is based around research and development of new drugs and vaccines and it can be difficult to keep track of new information. That’s why it’s a good idea to stay informed about the latest news which you can do so by clicking on the links below and by reading more on how to buy ETFs

Sign up to a broker to buy pharmaceutical ETFs

Latest pharmaceutical news

Copy link to section
Windtree Therapeutics Inc (NASDAQ: WINT) is down nearly 20% on Monday even though there hasn’t been any specific news that may have caused that decline.  Here’s what may be weighing on Windtree Therapeutics stock Investors may be continuing to respond to a few updates that $WINT has poste
Biotech stocks are having a relatively strong year as investors focus on the growing M&A in the healthcare space. Johnson & Johnson is acquiring Shockwave Medical while Novo Nordisk is buying Catalent, a CDMO organization. Pfizer acquired Seagen in 2023 while Merck bought Harpoon Therapeutic
Humacyte (NASDAQ: HUMA) stock price is pumping this week. It jumped by over 10% on Friday, continuing a spectacular rally that started last week. It has soared by 40% from its lowest point this month and is trading at its highest point since February 29th. The reason why the stock surged is because
Intuitive Surgical’s (NASDAQ: ISRG) stock price will be in the spotlight this week as the company publishes its financial results on Thursday. These results will come at a time when its recent rally has stalled. It was trading at $380 on Tuesday, lower than the year-to-date high of $404.  Intui
NextPlat Corp. (NASDAQ: NXPL) shares surged nearly 30% on Friday after the announcement of a definitive business combination agreement with its majority-owned subsidiary, Progressive Care Inc. (OTCQB: RXMD). What does NextPlat merger with Progressive Care mean? The merger between NextPlat and Progre
PaxMedica (NASDAQ: PXMD) has surged by 92.7% so far on Friday, reflecting the market’s positive reaction to the company’s announcement of significant progress in its drug development efforts. The company’s shares soared by 125% in post-market trading on Thursday after PaxMedica rev

Risk disclaimer
Prash Raval
Financial Writer
Prash is a financial writer for Invezz covering FX, the stock market and investing. For over a decade he has traded spot FX full time while... read more.